Tenax Therapeutics news: Company executes reverse stock split
Tenax Therapeutics executed a long planned reverse stock split earlier this week. Shares trade under the symbol TENX.
Read MorePosted by WRAL TechWire | Jan 6, 2023
Tenax Therapeutics executed a long planned reverse stock split earlier this week. Shares trade under the symbol TENX.
Read MorePosted by Jason Parker | May 20, 2022
A Morrisville-based publicly-traded company will bring in $8 million in capital through a transaction known as a private investment in public equity.
Read MorePosted by Jason Parker | Jul 22, 2021
Two weeks after announcing a leadership change and that the company would pursue a $10 million investment, Tenax Therapeutics has completed the stock sale, according to an SEC filing.
Read MorePosted by WRAL TechWire | Jul 7, 2021
Anthony DiTono is retiring as CEO of Tenax Therapeutics and will be replaced by Christopher Giordanao, a former senior executive at life science giant Iqvia.
Read MorePosted by WRAL TechWire | May 18, 2021
Precision Biosciences, Fathom Holdings and Tenax Therapeutics recently reported quarterly earnings. Here’s a recap.
Read MorePosted by WRAL TechWire | Jan 19, 2021
Tenax Therameputics is acquiring an Illinois-based biotech firm with a promising hypertension treatment and named that company’s cofounder as its chief medical officer. Shares soared on news of the deal.
Read MorePosted by WRAL TechWire | Jul 23, 2020
Tenax Therapeutics, formerly known as Oxygen Biotherapeutics, has raised $5 million from an investor, according to an SEC filing.
Read MorePosted by WRAL TechWire | Jan 19, 2018
Morrisville-based Tenax Therapeutics is asking shareholders to approve a reverse stock split.
Read More